Skip to content

To study the effect of an Oral Supplement on various skin aging parameters and any unwanted side-effect (if any) in women.

EVALUATION OF THE EFFICACY AND IN USE TOLERANCE OF A SKIN ANTI AGEING NUTRACEUTICAL PRODUCT IN WOMEN

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014808
Enrollment
36
Registered
2018-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nutrova Collagen & Antioxidant: Contents of the sachet to be mixed with water and consumed every night after dinner for 60 days Control Intervention1: Placebo: Contents of the sachet to

Sponsors

Axys Nutrition Products Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Voluntary women with mild to moderate wrinkles. - Having at least 1 hyperpigmented spot. - Having undereye dark circles. - Food habit - Non-vegetarians or consented vegetarian. - Subjects not on any nutritional supplement or not consuming any therapeutic medication for any disorder for last 45 days.

Exclusion criteria

Exclusion criteria: - Subjects with any chronic illness or any clinical condition. - Subjects showing abnormal levels in blood test parameters. - Pregnant Women (as confirmed via UPT) and lactating women. - Subject likely to undergo any surgery in the period of the study. - Subjects who have used a collagen peptide containing supplement in the past 6 months. - Subjects consuming tobacco. - Obese individuals (BMI >30).

Design outcomes

Primary

MeasureTime frame
Clinical Evaluation of Wrinkles in crowâ??s feet area, Blemishes and Undereye dark circle Instrumental evaluation using 3D imaging (Wrinkles, blemish, Average Pore volume and Porosity index, Roughness), MoistureMeter SC (hydration), Vapometer (TEWL) and Cutometer (firmness and elasticity) Subjective self-assessment for product efficacy (Not at Day -30)Timepoint: Day -30 Day 0 Day 30 Day 60

Secondary

MeasureTime frame
Self-evaluation questionnaire to capture tolerabilityTimepoint: Day 0 Day 30 Day 60

Countries

India

Contacts

Public ContactDr Meghna Motwani

Axys Nutrition Products Pvt. Ltd.

meghna.motwani@nutrova.com9820471974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026